Effect of scheduled intravenous acetaminophen on postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery

被引:6
|
作者
Taniguchi, Hideki [1 ]
Nagahuchi, Mari [2 ]
Kamada, Takaaki [2 ]
Suga, Kikuko [2 ]
Sato, Tomoyuki [2 ]
Ueda, Tomomi [2 ]
Yamamoto, Tatsuo [2 ]
机构
[1] Saiseikai Yokohamashi Tobu Hosp, Perioperat Support Ctr, Tsurumi Ku, 3-6-1 Shimo Sueyoshi, Yokohama, Kanagawa 2308765, Japan
[2] Saiseikai Yokohamashi Tobu Hosp, Dept Anesthesiol, Yokohama, Kanagawa, Japan
关键词
Scheduled intravenous acetaminophen; Acetaminophen; Laparoscopic gynecologic surgery; Opioid sparing; Postoperative nausea and vomiting; RANDOMIZED CONTROLLED-TRIAL; ENHANCED RECOVERY; PERIOPERATIVE CARE; PAIN MANAGEMENT; GUIDELINES; PLASMA; STAY; ERAS;
D O I
10.1007/s00540-020-02777-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose The aim of this study was to assess the effect of scheduled intravenous acetaminophen (SIVA) on the incidence of postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic gynecologic surgery (LGS). Methods This retrospective observational study identified consecutive patients who underwent LGS at our institution from January to November of 2017 and were managed with either our hospital's old protocol (Group H) or a new protocol using SIVA (Group S). Primary outcomes included the incidences of PONV and the amount of additional antiemetic required in the postoperative period. The secondary outcomes included the pain score on postoperative day 1, the requirement for additional analgesic medications, and the length of hospitalization (LOH). Results Patients in Group S had significantly lower incidences of PONV from postoperative days 0 to 1 and required significantly less antiemetics or tramadol than those in Group H (P = 0.0085). Patients at a low risk for PONV in Group S had significantly lower incidences of PONV than those in Group H (P = 0.0129). Further, the amount of additional tramadol required was lower in Group S than in Group H (P = 0.0021). Conclusion Introduction of SIVA into the postoperative pain management protocol of LGS may reduce the incidence of PONV and the amount of adjunctive antiemetic medication required from postoperative days 0 to 1. In patients undergoing LGS, PONV prophylaxis using antiemetics should be prescribed depending on PONV risk profile; however, SIVA prophylaxis can be used in all patients regardless of PONV risk profile.
引用
收藏
页码:502 / 511
页数:10
相关论文
共 50 条
  • [31] The influence of dexamethasone on postoperative nausea and vomiting in patients undergoing gynecologic laparoscopic surgeries: A randomised, controlled, double blind trial
    Asadollah, Sara
    Vahdat, Mansoureh
    Yazdkhasti, Payman
    Nikravan, Nasrin
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 11 (04) : 219 - 223
  • [32] Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy
    Kaki, Abdullah M.
    El-Hakeen, Essam E. Abd
    SAUDI MEDICAL JOURNAL, 2008, 29 (10) : 1408 - 1413
  • [33] Comparative study on effects of dexmedetomidine and dexamethasone on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic surgery
    Singh, Manpreet
    Tiwari, AwadhBihari
    Taank, Priya
    Singh, Shalendra
    Kaur, Amrinder
    Sood, Munish
    Yadav, Rahul
    JOURNAL OF ACUTE DISEASE, 2022, 11 (02) : 59 - 64
  • [34] Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial
    Chen, Nanjin
    Ji, Shuman
    Liu, Junfei
    Wang, Liping
    Chen, Fenglin
    Zhu, Yanwu
    Li, Jiao
    Chen, Minjuan
    Chen, Lingyang
    Wang, Mingcang
    He, Ruyi
    Mei, Xiaopeng
    Zhang, Zhanqin
    Jin, Shengwei
    Zheng, Jingming
    Jiang, Yongpo
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2024, 15
  • [35] Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery
    Fujii, Yoshitaka
    Tanaka, Hiroyoshi
    Somekawa, Yoshiaki
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (06)
  • [36] Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery
    Diemunsch, P
    DHollander, A
    Paxton, L
    Schoeffler, P
    Wessel, P
    Nave, S
    Brown, RA
    Hahne, WF
    JOURNAL OF CLINICAL ANESTHESIA, 1997, 9 (05) : 365 - 373
  • [37] Predicting postoperative nausea and vomiting in patients undergoing oral and maxillofacial surgery
    Laskin, D. M.
    Carrico, C. K.
    Wood, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2020, 49 (01) : 22 - 27
  • [38] Retraction Note: Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
    Yoshitaka Fujii
    Surgical Endoscopy, 2013, 27 : 2250 - 2250
  • [39] RETRACTED ARTICLE: Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
    Yoshitaka Fujii
    Surgical Endoscopy, 2011, 25 : 691 - 695
  • [40] Effect of intraoperative noise isolation on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: protocol for a randomized controlled trial
    Fu, Chong
    Xia, Fan
    Yan, Zihan
    Xu, Han-bing
    Zhao, Wei-ming
    Lei, Yi-shan
    Xu, Chang
    Huo, Wen-wen
    Tao, Duo-duo
    Wang, Juan
    Shan, Xi-sheng
    Peng, Ke
    Liu, Hong
    Ji, Fu-hai
    Liu, Hua-yue
    BMC ANESTHESIOLOGY, 2025, 25 (01):